Cancer

A new analysis from MIT researchers has found that preventative screenings such as a colonoscopy and sigmoidoscopy can reduce cancer rates more than previous analyses suggested, reports Ernie Mundell for HealthDay. “Prior colon cancer screening studies found that regular colonoscopy/sigmoidoscopy reduced that rate by 25% -- to 0.75%,” explains Mundell. “But the new analysis took into account the number of participants in a colon cancer screening trial who decided, for whatever reason, to skip screening. When these "non-adherent" folks were eliminated from statistical calculations, the actual percentage of people who went on to develop colon cancer over a 10-year span fell to just 0.5%.”

Forbes contributor William Haseltine spotlights how MIT researchers have developed a flexible ultrasound patch that can be used to help estimate bladder volume. “The applications for long-term therapeutic and regenerative medicine for the ultrasound patch are innumerable, only to be limited by the imagination of those implementing their use,” writes Haseltine. “Among the most forthcoming are situations where someone may be unable to visit their physician for a medically-administered ultrasound.”

Prof. Rudolf Jaenisch speaks with Fortune reporter Carolyn Barber about the immune system’s response to Covid-19. “The immune system is really stimulated–it’s in hyperdrive,” says Jaenisch. 

Researchers at MIT and elsewhere have developed a new type of cancer treatment – a gel that can be used to deliver cancer drugs for solid tumors, reports WHDH. “It’s really transformative to try and help patients whose tumors are very resistant to therapy,” says Prof. Giovanni Traverso.

MIT researchers have designed a wearable ultrasound device that could help make breast cancer screening more accessible, reports Carrie Arnold for National Geographic.  “Early detection is the key for survival,” says Prof. Canan Dagdeviren. “Our humble calculation shows that this technology has the potential to save 12 million lives per year globally.”

Holly Metcalf, head coach for the MIT women’s openweight rowing team, speaks with Esteban Bustillos of GBH News about the Survivor Rowing Network, a program aimed at introducing the sport of rowing to cancer survivors. Metcalf is coaching two boats from the Survivor Rowing in the 2023 Head of the Charles Regatta. “What I love about being here is students are visionary. And big world problems, they want to solve them. So maybe here at MIT one of my students may have an answer to getting rid of cancer,” she said. “That’s here. It’s all about finding answers through collaboration and that’s what rowing is, it’s a collaboration of mind, of body.”

Researchers at MIT have designed “a wearable ultrasound scanner that could be used at home to detect breast tumors earlier,” reports Simon Makin for Scientific American. “The researchers incorporated the scanner into a flexible, honeycombed 3-D-printed patch that can be fixed into a bra,” explains Makin. “The wearer moves the scanner among six different positions on the breast, where it snaps into place with magnets, allowing reproducible scanning of the whole breast.”

MIT's Women's Rowing Coach Holly Metcalf speaks with CBS Boston about the Survivors Rowing Network, a team of breast cancer survivors who are rowing in the Head of the Charles Regatta. Metcalf, who is serving as the team’s coach, says that: "I am here to cheer them on. To see the strength and the trust that comes back for people who are surviving cancer. Trust in their bodies.” 

Researchers at MIT have developed a wearable ultrasound device that can be used to detect early signs of breast cancer, reports Rachel Keller and Bob Dumas for Boston 25 News. “This technology will be able to let you know if there’s a question mark, if there’s an anomaly, in your breast tissue,” says Prof. Canan Dagdeviren.

Researchers at MIT and Dana-Farber Cancer Institute have published a paper showcasing the development of OncoNPC, an artificial intelligence model that can predict where a patient’s cancer came from in their body, reports Tony Ho Tran for The Daily Beast. This information “can help determine more effective treatment decisions for patients and caregivers,” writes Tran.

Prof. Canan Dagdeviren and colleagues at MIT have developed a wearable sensor that could help more easily detect breast cancer. “Dr. Dagdeviren hopes the device will allow for more frequent screening of women who are at high risk of developing breast cancer, such as those who had inherited the BRCA1 and BRCA2 genes, or people who have had cancer previously,” writes Sarah Knapton for The Telegraph.  

Researchers at MIT have developed a wearable ultrasound patch that could be used to allow women to monitor themselves for early signs of breast cancer, reports Amy Norton for HealthDay. “The hope is to one day use such portable technology to help diagnose and monitor a range of diseases and injuries – in a way that’s more accessible and cheaper than using traditional scanners housed at medical facilities,” explains Norton.

Researchers at MIT have developed a “flexible patch that can take ultrasound images comparable to those done by medical centers, but can fit into a bra,” reports Sara Kiley Watson for Popular Science. “The researchers tested their device on a 71-year-old subject with a history of breast cysts, and were able to detect cysts as small as 0.3 centimeters in diameter up to 8 centimeters deep in the tissue, all while maintaining a resolution similar to traditional ultrasounds,” writes Kiley Watson.

MIT researchers have designed a wearable ultrasound device that attaches to a bra and could be used to detect early-stage breast tumors, reports Lizzy Lawrence for STAT. “I’m hoping to really make it real, and to touch people’s lives,” says Prof. Canan Dagdeviren. “I want to see the impact of my technology not only in the lab, but on society.”

Researchers from MIT and Massachusetts General Hospital have developed “Sybil,” an AI tool that can detect the risk of a patient developing lung cancer within six years, reports Mary Kekatos for ABC News. “Sybil was trained on low-dose chest computer tomography scans, which is recommended for those between ages 50 and 80 who either have a significant history of smoking or currently smoke,” explains Kekatos.